Pace Life Sciences Acquires Biopharma Global

Pace Life Sciences Acquires Meridian BioGroup

August 18, 2022

Healthcare Services

Pace Life Sciences, a CDMO and subsidiary of Pace Science and Technology Company, has acquired Meridian BioGroup, a validation, regulatory, and compliance consulting provider based in Frederick, Maryland. The deal expands Pace's regulatory, quality and validation capabilities to better support biotechnology and pharmaceutical clients across development and commercialization.

Pace Life Sciences (Pace Analytical) Acquires Drug Delivery Experts

July 23, 2021

Pharmaceuticals

Pace Analytical Life Sciences, a CDMO subsidiary of Pace Analytical Services (itself a portfolio company of Aurora Capital Partners), has acquired Drug Delivery Experts, LLC, a San Diego-based CDMO specializing in complex injectable formulations and drug‑device combination product development. The acquisition expands Pace’s injectable and long‑acting/extended‑release capabilities and brings DDE’s scientific leadership into Pace’s west‑coast operations as DDE transitions to the Pace brand.

Pace Analytical Life Sciences Acquires Bio-Concept Laboratories

December 8, 2020

Pharmaceuticals

Pace Analytical Life Sciences, a subsidiary of Pace Analytical Services, acquired Bio-Concept Laboratories, a Salem, New Hampshire-based pharmaceutical CDMO specializing in sterile aqueous formulation development and fill–finish manufacturing. The deal expands Pace’s sterile materials and ophthalmic manufacturing capabilities to better support clinical trial and drug development programs and strengthens its New England CDMO footprint.

Leonard Green & Partners Acquires Majority Stake in Pace from Aurora Capital Partners

January 11, 2022

Healthcare Services

Leonard Green & Partners (LGP) acquired a majority stake in Pace, a North American provider of analytical and life sciences testing and outsourced scientific solutions, from Aurora Capital Partners; Aurora has reinvested alongside LGP. Founded in 1978, Pace operates a nationwide network of over 65 analytical testing laboratories, 8 life sciences labs, and more than 45 service centers; financial terms were not disclosed.

Pace Analytical Acquires Emerson Resources, Inc.

August 25, 2020

Pharmaceuticals

Pace Analytical Services, LLC acquired Emerson Resources, Inc., a CDMO specializing in solid oral dosage development and cGMP clinical trial material manufacturing. The acquisition expands Pace Life Sciences' capabilities to include clinical trial material production and transitions Emerson's Norristown, Pennsylvania lab into the Pace Analytical network while Emerson principals exit the business.

Interpace Diagnostics Acquires Cancer Genetics' Biopharma Services Business

July 15, 2019

Healthcare Services

Interpace Diagnostics Group, Inc. acquired assets and certain liabilities comprising the Biopharma Services business of Cancer Genetics, Inc. for approximately $23.5 million, with the business continuing to operate from labs in Rutherford, New Jersey and Research Triangle Park, North Carolina. In conjunction with the transaction Ampersand Capital Partners invested $27 million in Interpace via convertible preferred stock to support the acquisition and Interpace’s growth in the clinical diagnostic and biopharma services markets.